A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant
- 23 September 2005
- Vol. 23 (40) , 4834-4843
- https://doi.org/10.1016/j.vaccine.2005.05.010
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- GnRH antagonists in the treatment of gynecological and breast cancers.Endocrine-Related Cancer, 2003
- Influence of Carrier Protein Conjugation Site and Terminal Modification of a GnRH-I Peptide Sequence in the Development of a Highly Specific Anti-fertility Vaccine. Part IAmerican Journal of Reproductive Immunology, 2002
- Vaccines and passive immunological approaches for the control of fertility and hormone‐dependent cancersImmunological Reviews, 1999
- Highly immunogenic and fully synthetic peptide-carrier constructs targetting GNRHVaccine, 1999
- Specificity of antibodies induced after immunization of mice with the mycobacterial heat shock protein of 65 kDClinical and Experimental Immunology, 1994
- Hypothalamic hormonesAnti-Cancer Drugs, 1994
- Successful primate immunization with peptides conjugated to purified protein derivative or mycobacterial heat shock proteins in the absence of adjuvantsClinical and Experimental Immunology, 1993
- Synthetic gonadotrophin-releasing hormone (GnRH) vaccines incorporating GnRH and synthetic T-helper epitopesVaccine, 1993
- Differential pattern of T cell recognition of the 65‐kDa mycobacterial antigen following immunization with the whole protein or peptidesEuropean Journal of Immunology, 1989
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970